(no photo available) 96 tests $974 KT-61041 4-aminobutye aminotransferase, mitochondrial (ABAT) ELISA Kit, Human For quantitative detection in human samples
Redox metals homeostasis in multiple sclerosis and amyotrophic lateral sclerosis: a review
PMID: 28585735 Article Published Date : Jul 01, 2017 Study Type : Human Study [+] Deficiency of 25(OH)D3, a potentially modifiable risk factor, independently predicted cognitive impairment in SLE patients.Dec 31, 2014 Click here to read the entire abstract Article Publish Status : This is a free article
Introduction P|ESG Approach Impact Ambitions 40 2025 and 2026 Corporate Responsibility and P|ESG Ambitions 2025 Ambitions Status Description 2026 Ambitions Ascendis Pharma continues to grow with a Attraction, onboarding and Attraction, onboarding and retention of talent continued focus to attract and retain the right retention of talent to ensure we to ensure we have the right people to deliver on Ongoing talent to deliver on the Ascendis Pharma have the right people to deliver on our ambitions
doi: 10.1016/S2352-4642(18)30385-7 [DOI] [PubMed] [Google Scholar] 168
Your questions, our answers
